ANCA-associated vasculitis: diagnosis and treatment in the elderly.
We report the successful treatment of three patients with ANCA-associated vasculitis aged 79, 80, and 80 years. We also review other published reports of treatment in the elderly and discuss complications of treatment with emphasis on elderly patients.
Parry
R
R
Department of Medicine for the Elderly, Royal Bournemouth Hospital, UK.
Sherwin
S
S
Fletcher
V
V
Medcalf
P
P
D000368:Aged; D000369:Aged, 80 and over; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001323:Autoantibodies / Q000097:blood; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D009504:Neutrophils / Q000276:immunology; D011239:Prednisolone / Q000627:therapeutic use*; D014657:Vasculitis / Q000175:diagnosis / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D001323:Autoantibodies; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D011239:Prednisolone